Home » Topics » Science » New compound

New compound
RSS

HFB-200301 shows potential as novel immunotherapeutic agent in vivo

July 17, 2020

Discovery of PQR-626, a potent and brain-penetrant mTOR inhibitor

July 16, 2020

Galectin-9 monoclonal antibody HFB9-2 displays favorable characteristics for further development

July 15, 2020

CCX-6569 shows promising antitumor activity in model of colon adenocarcinoma

July 14, 2020

Discovery of KB-00130742 as orally bioavailable and ultra-selective inhibitor of CDK9

July 14, 2020

Recombinant Bifidobacterium longum APS-002 secretes T-cell-redirecting diabody DBERB1

July 14, 2020

Aligos Therapeutics presents preclinical data on ALG-031048

July 13, 2020

Discovery of novel BET protein degraders as oncolytic drug candidates

July 13, 2020

Pan-TRK/ROS1 dual inhibitor XZP-5955 shows brain penetration, activity against mutations

July 10, 2020

Anti-CCR8 MAb BMS-986340 shows promise as cancer immunotherapeutic

July 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...